Xu ML - Search Results

1

IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas.

McQuaid DC, Katz SG, Xu ML. McQuaid DC, et al. Among authors: xu ml. Am J Clin Pathol. 2022 Aug 4;158(2):173-176. doi: 10.1093/ajcp/aqac044. Am J Clin Pathol. 2022. PMID: 35460405 Free PMC article.

2

PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies.

Chen BJ, Chapuy B, Ouyang J, Sun HH, Roemer MG, Xu ML, Yu H, Fletcher CD, Freeman GJ, Shipp MA, Rodig SJ. Chen BJ, et al. Among authors: xu ml. Clin Cancer Res. 2013 Jul 1;19(13):3462-73. doi: 10.1158/1078-0432.CCR-13-0855. Epub 2013 May 14. Clin Cancer Res. 2013. PMID: 23674495 Free PMC article.

3

Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability.

Ho C, Yao X, Tian L, Li FY, Podoltsev N, Xu ML. Ho C, et al. Among authors: xu ml. Am J Clin Pathol. 2014 Jan;141(1):62-71. doi: 10.1309/AJCPMD5TJEFOOVBW. Am J Clin Pathol. 2014. PMID: 24343738

4

Expression of CD30 as a biomarker to predict response to brentuximab vedotin.

Xu ML, Acevedo-Gadea C, Seropian S, Katz SG. Xu ML, et al. Histopathology. 2016 Jul;69(1):155-8. doi: 10.1111/his.12914. Epub 2016 Jan 26. Histopathology. 2016. PMID: 26648051 Free PMC article. No abstract available.

5

Dendritic Cell Markers and PD-L1 are Expressed in Mediastinal Gray Zone Lymphoma.

Pelland K, Mathews S, Kamath A, Cohen P, Hudnall SD, Cotta CV, Xu ML. Pelland K, et al. Among authors: xu ml. Appl Immunohistochem Mol Morphol. 2018 Nov/Dec;26(10):e101-e106. doi: 10.1097/PAI.0000000000000615. Appl Immunohistochem Mol Morphol. 2018. PMID: 29189264

6

Small Cell Variant of Intravascular Large B-Cell Lymphoma: Highlighting a Potentially Fatal and Easily Missed Diagnosis.

Rahmani M, Halene S, Xu ML. Rahmani M, et al. Among authors: xu ml. Biomed Res Int. 2018 Apr 3;2018:9413015. doi: 10.1155/2018/9413015. eCollection 2018. Biomed Res Int. 2018. PMID: 29850589 Free PMC article.

7

Mantle Cell Lymphoma With Mantle Zone Growth Pattern.

Yuan J, Li S, Liu X, Su RJ, Chen M, Wu X, Zheng G, Smith LM, Wang L, Li Y, Liu C, Zhou J, Shen Q, Zhang L, Wang E, Xu ML, Pan Z. Yuan J, et al. Among authors: xu ml. Am J Clin Pathol. 2019 Jul 5;152(2):132-145. doi: 10.1093/ajcp/aqz043. Am J Clin Pathol. 2019. PMID: 31140550

8

Clinicopathologic characteristics and novel biomarkers of aggressive B-cell lymphomas in the nasopharynx.

Chen PH, Yang Y, O'Malley DP, Xu ML. Chen PH, et al. Among authors: xu ml. Ann Diagn Pathol. 2019 Aug;41:129-135. doi: 10.1016/j.anndiagpath.2019.06.007. Epub 2019 Jun 17. Ann Diagn Pathol. 2019. PMID: 31247533

9

Histiocytic and Dendritic Cell Neoplasms.

Pan Z, Xu ML. Pan Z, et al. Among authors: xu ml. Surg Pathol Clin. 2019 Sep;12(3):805-829. doi: 10.1016/j.path.2019.03.013. Epub 2019 Jun 8. Surg Pathol Clin. 2019. PMID: 31352989 Review.

10

Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma.

Wang JD, Katz SG, Morgan EA, Yang DT, Pan X, Xu ML. Wang JD, et al. Among authors: xu ml. Hum Pathol. 2019 Nov;93:54-64. doi: 10.1016/j.humpath.2019.08.008. Epub 2019 Aug 16. Hum Pathol. 2019. PMID: 31425695 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters